Galera Therapeutics, Inc. (GRTX) Retained Earnings (Accumulated Deficit) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Galera Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2018 to 2024.
  • Galera Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$442 M, a 11.6% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$442 M -$45.8 M -11.6% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$437 M -$59.1 M -15.6% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 -$432 M -$69.7 M -19.2% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$417 M -$70.6 M -20.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$396 M -$64.5 M -19.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$378 M -$62.2 M -19.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$362 M -$62.8 M -21% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$346 M -$69.4 M -25.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$332 M -$77.3 M -30.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$316 M -$80.5 M -34.2% Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$299 M -$83.8 M -38.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$277 M -$78.2 M -39.4% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$254 M -$74.5 M -41.5% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 -$236 M -$74.2 M -46% Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$216 M -$70.8 M -49% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 -$198 M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$180 M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 -$161 M -$56.5 M -53.9% Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$145 M Sep 30, 2019 10-Q 2019-12-10
Q4 2018 -$105 M Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.